Showing results (1921-1930 of 1,952) with videos related to
Sort By:
Pageof 196
Advanced Healthcare Materials|March 27, 2014
Multifunctional skin-like electronics for quantitative, clinical monitoring of cutaneous wound healingYoshiaki Hattori, Leo Falgout, Woosik Lee, et al.Nature Communications|March 19, 2015
Soft network composite materials with deterministic and bio-inspired designsKyung-In Jang, Ha Uk Chung, Sheng Xu, et al.Psychiatry Investigation|June 26, 2025
Transcriptional Landscape and Biomarker Discovery for Endoplasmic Reticulum Stress in Alzheimer's Disease: An Ex Vivo Study Using Patients-Derived Dermal FibroblastsYeojin Kim, You Jin Nam, Sunwoo Yoon, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 9, 2010
[Overview of chronic myelogenous leukemia and its current diagnosis and treatment patterns in 15 hospitals in China.]Jian-Xiang Wang, Xiao-Jun Huang, De-Pei Wu, et al.Trials|July 3, 2019
Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trialMin-Gu Kang, Kwang-Il Kim, Sang Hyun Ihm, et al.Cell|August 14, 2018
Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear ImportVeronica Rodriguez-Bravo, Raffaella Pippa, Won-Min Song, et al.ACS Nano|April 12, 2018
Three-Dimensional Silicon Electronic Systems Fabricated by Compressive Buckling ProcessBong Hoon Kim, Jungyup Lee, Sang Min Won, et al.Clinical Transplantation|October 26, 2025
The Eastern Cooperative Oncology Group Score Rather Than Donor Type Impacts Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia Patients Aged 51-60 Years: A Retrospective Study From the Chinese Blood and Marrow Transplant RegistryXin Zhao, Ming Zhou, Bao-Dong Ye, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2021
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO GuidelineBianca D Santomasso, Loretta J Nastoupil, Sherry Adkins, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2021
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline UpdateBryan J Schneider, Jarushka Naidoo, Bianca D Santomasso, et al.Pageof 196